'Life-changing' cancer drug that can help patients live longer approved for NHS use
Olaparib targets cancers with BRCA 1 or BRCA 2 mutations, stopping cancer cells from being able to repair their DNA, which in turn causes the cancerous cells to die.
Continue Reading https://news.sky.com
Join the Discussion